Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 5;315(13):1400-2.
doi: 10.1001/jama.2016.0126.

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

Xinyang Hua  1 , Natalie Carvalho  1 , Michelle Tew  1 , Elbert S Huang  2 , William H Herman  3 , Philip Clarke  1
Affiliations

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

Xinyang Hua et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. No other disclosures were reported.

Figures

Figure
Figure. Mean Expenditure per Patient for Antihyperglycemic Medications, 2002–2013
Medications were classified as follows: insulin (human and analog); newer oral therapies (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, and combinations); older oral therapies (metformin, sulfonylureas, α-galactosidase inhibitors, and nonsulfonylurea secretagogues); noninsulin-based injectable therapies (glucagon-like peptide-1 receptor agonists and amylin analogs).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lipska KJ, Ross JS, Van Houten HK, Beran D, Yudkin JS, Shah ND. Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. JAMA. 2014;311(22):2331–2333. - PMC - PubMed
    1. Luo J, Avorn J, Kesselheim AS. Trends in Medicaid reimbursements for insulin from 1991 through 2014. JAMA Intern Med. 2015;175(10):1681–1686. - PubMed
    1. Zhuo X, Zhang P, Kahn HS, Bardenheier BH, Li R, Gregg EW. Change in medical spending attributable to diabetes: national data from 1987 to 2011. Diabetes Care. 2015;38(4):581–587. - PubMed
    1. Agency for Health Care Research and Quality. MEPS HC-155: 2012 full year consolidated data file. [Accessed September 23, 2015]; http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h155/h155doc.pdf.
    1. Greene JA, Riggs KR. Why is there no generic insulin? historical origins of a modern problem. N Engl J Med. 2015;372(12):1171–1175. - PubMed

Publication types